Enke Baldini

3.4k total citations
90 papers, 2.3k citations indexed

About

Enke Baldini is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Molecular Biology. According to data from OpenAlex, Enke Baldini has authored 90 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Endocrinology, Diabetes and Metabolism, 30 papers in Oncology and 28 papers in Molecular Biology. Recurrent topics in Enke Baldini's work include Thyroid Cancer Diagnosis and Treatment (37 papers), Cancer-related Molecular Pathways (18 papers) and Microtubule and mitosis dynamics (16 papers). Enke Baldini is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (37 papers), Cancer-related Molecular Pathways (18 papers) and Microtubule and mitosis dynamics (16 papers). Enke Baldini collaborates with scholars based in Italy, France and United States. Enke Baldini's co-authors include Salvatore Ulisse, Salvatore Sorrenti, M D’Armiento, Alessandro Antonelli, Poupak Fallahi, A Catania, Silvia Martina Ferrari, Daniele Pironi, Costanzo Moretti and Enrico De Antoni and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Biochemical and Biophysical Research Communications.

In The Last Decade

Enke Baldini

89 papers receiving 2.2k citations

Peers

Enke Baldini
Thomas D. Manes United States
R Rubin United States
Suhad Ali Canada
Carla Costa Portugal
Anja Steffen Germany
Enke Baldini
Citations per year, relative to Enke Baldini Enke Baldini (= 1×) peers Ana Sofia Rocha

Countries citing papers authored by Enke Baldini

Since Specialization
Citations

This map shows the geographic impact of Enke Baldini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enke Baldini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enke Baldini more than expected).

Fields of papers citing papers by Enke Baldini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enke Baldini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enke Baldini. The network helps show where Enke Baldini may publish in the future.

Co-authorship network of co-authors of Enke Baldini

This figure shows the co-authorship network connecting the top 25 collaborators of Enke Baldini. A scholar is included among the top collaborators of Enke Baldini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enke Baldini. Enke Baldini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferrari, Silvia Martina, Armando Patrizio, Valeria Mazzi, et al.. (2024). Lactose intolerance and levothyroxine malabsorption: a review of the literature and report of a series of patients treated with liquid L-T4 without lactose. Frontiers in Endocrinology. 15. 1386510–1386510. 1 indexed citations
2.
Baldini, Enke, Silvia Cardarelli, Eleonora Lori, et al.. (2024). The Potential Therapeutic Value of Aspirin in Anaplastic Thyroid Cancer. Cancers. 16(24). 4203–4203. 1 indexed citations
3.
Baldini, Enke, Silvia Cardarelli, Antonio Francesco Campese, et al.. (2024). Evaluation of the Therapeutic Effects of Harmine on Anaplastic Thyroid Cancer Cells. International Journal of Molecular Sciences. 25(2). 1121–1121. 5 indexed citations
4.
Russo, Anna, Claudio Sini, Diego Cortinovis, et al.. (2024). 1301P BRAF-mutant metastatic non-small cell lung cancer: Real-world data from the Italian biomarker ATLAS database. Annals of Oncology. 35. S828–S828.
5.
Baldini, Enke, Eleonora Lori, Silvia Cardarelli, et al.. (2023). Insights on the Association between Thyroid Diseases and Colorectal Cancer. Journal of Clinical Medicine. 12(6). 2234–2234. 5 indexed citations
6.
Fallahi, Poupak, Giusy Elia, Francesca Ragusa, et al.. (2023). Thyroid Autoimmunity and SARS-CoV-2 Infection. Journal of Clinical Medicine. 12(19). 6365–6365. 13 indexed citations
7.
Tozzi, Rossella, Federica Campolo, Enke Baldini, et al.. (2022). Ketogenic Diet Increases Serum and White Adipose Tissue SIRT1 Expression in Mice. International Journal of Molecular Sciences. 23(24). 15860–15860. 9 indexed citations
8.
Tozzi, Rossella, Davide Masi, Savina Contini, et al.. (2022). Circulating SIRT1 and Sclerostin Correlates with Bone Status in Young Women with Different Degrees of Adiposity. Nutrients. 14(5). 983–983. 7 indexed citations
9.
Sorrenti, Salvatore, Enke Baldini, Daniele Pironi, et al.. (2021). Iodine: Its Role in Thyroid Hormone Biosynthesis and Beyond. Nutrients. 13(12). 4469–4469. 75 indexed citations
10.
Nozhat, Zahra, Maryam Zarkesh, Enke Baldini, et al.. (2021). Antineoplastic Activity of an Old Natural Antidiabetic Biguanide on the HumanThyroid Carcinoma Cell Line. Anti-Cancer Agents in Medicinal Chemistry. 22(4). 713–720. 2 indexed citations
11.
Cianfarani, Francesca, Alexander Nyström, Simona Mastroeni, et al.. (2018). Decorin counteracts disease progression in mice with recessive dystrophic epidermolysis bullosa. Matrix Biology. 81. 3–16. 38 indexed citations
12.
Baldini, Enke, Salvatore Sorrenti, Francesco Tartaglia, et al.. (2017). New perspectives in the diagnosis of thyroid follicular lesions. International Journal of Surgery. 41. S7–S12. 6 indexed citations
13.
Fallahi, Poupak, Silvia Martina Ferrari, Enke Baldini, et al.. (2016). The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer. Expert Review of Anticancer Therapy. 16(11). 1109–1118. 22 indexed citations
14.
Pezzani, Raffaele, Beatrice Rubin, Loris Bertazza, et al.. (2016). The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line. Investigational New Drugs. 34(5). 531–540. 14 indexed citations
15.
Ferrari, Silvia Martina, Gabriele Materazzi, Enke Baldini, et al.. (2016). Antineoplastic Effects of PPAR? Agonists, with a Special Focus on Thyroid Cancer. Current Medicinal Chemistry. 23(7). 636–649. 17 indexed citations
16.
Ferrari, Silvia Martina, Roberto Spisni, Gabriele Materazzi, et al.. (2015). Sorafenib in the treatment of thyroid cancer. Expert Review of Anticancer Therapy. 15(8). 863–874. 20 indexed citations
17.
Ferrari, Silvia Martina, Concettina La Motta, Stefania Sartini, et al.. (2015). Pyrazolopyrimidine Derivatives as Antineoplastic Agents: with a Special Focus on Thyroid Cancer. Mini-Reviews in Medicinal Chemistry. 16(2). 86–93. 17 indexed citations
18.
Prinzi, Natalie, Enke Baldini, Salvatore Sorrenti, et al.. (2014). Prevalence of breast cancer in thyroid diseases: results of a cross-sectional study of 3,921 patients. Breast Cancer Research and Treatment. 144(3). 683–688. 35 indexed citations
19.
Baldini, Enke, Salvatore Sorrenti, Chiara Tuccilli, et al.. (2014). Emerging molecular markers for the prognosis of differentiated thyroid cancer patients. International Journal of Surgery. 12. S52–S56. 14 indexed citations
20.
Baldini, Enke, Yannick Arlot‐Bonnemains, Salvatore Sorrenti, et al.. (2011). Aurora kinases are expressed in medullary thyroid carcinoma (MTC) and their inhibition suppresses in vitro growth and tumorigenicity of the MTC derived cell line TT. BMC Cancer. 11(1). 411–411. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026